NewAmsterdam Pharma Company NV
F:KH6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
NewAmsterdam Pharma Company NV
F:KH6
|
NL |
|
G
|
General Dynamics Corp
F:GDX
|
US |
|
Six Flags Entertainment Corp
F:6FE0
|
US |
|
K
|
Kalbe Farma Tbk PT
XMUN:LCLA
|
ID |
|
O
|
Odfjell Drilling Ltd
XMUN:OD3
|
BM |
|
R
|
Randstad NV
XMUN:RSH
|
NL |
|
A
|
Apple Inc
MIL:AAPL
|
US |
|
C
|
Cochlear Ltd
XMUN:OC5
|
AU |
|
C
|
CF Industries Holdings Inc
XMUN:C4F
|
US |
|
C
|
Continental AG
XMUN:CON
|
DE |
|
B
|
Boeing Co
SWB:BCO
|
US |
|
U
|
UniCredit SpA
XMUN:CRIN
|
IT |
|
Kardex Holding AG
SIX:KARN
|
CH |
|
L
|
Logan Energy Corp
XTSX:LGN
|
CA |
|
L
|
Laboratory Corporation of America Holdings
XBER:LAB
|
US |
|
B
|
Basf Se
SWB:BASA
|
DE |
|
S
|
Shin-Etsu Chemical Co Ltd
XBER:SEH
|
JP |
|
K
|
Keurig Dr Pepper Inc
XMUN:DP5
|
US |
|
Orix Corp
F:OIX
|
JP |
|
T
|
T Rowe Price Group Inc
DUS:TR1
|
US |
|
Aker ASA
F:FKM
|
NO |
Wall St Price Targets
KH6 Price Targets Summary
NewAmsterdam Pharma Company NV
According to Wall Street analysts, the average 1-year price target for KH6 is 56.42 EUR with a low forecast of 40.88 EUR and a high forecast of 67.1 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is KH6's stock price target?
Price Target
56.42
EUR
According to Wall Street analysts, the average 1-year price target for KH6 is 56.42 EUR with a low forecast of 40.88 EUR and a high forecast of 67.1 EUR.
What is the Revenue forecast for NewAmsterdam Pharma Company NV?
Projected CAGR
32%
The compound annual growth rate for Revenue over the next 11 years is 32%.